Oncoinvent has published Phase 1 dosimetry data for Radspherin in [...]

The FDA has issued a Complete Response Letter for ITM-11, [...]

A new AI model has generated patient-specific radiation dose-rate maps [...]

Telix has dosed the first patient in a Phase 3 [...]

Nucs AI has partnered with healthcare data specialist Segmed to [...]

The first patients have been dosed with MP0712, a DLL3-targeted [...]

Telix Pharmaceuticals has received FDA agreement on the protocol and [...]

Phase 3 data presented at ASCO 2026 suggest a PSMA-targeted [...]

Oncodesign Services has expanded its collaboration with French research institute [...]

Regeneron Pharmaceuticals has entered the radiopharmaceuticals field through a multi-programme [...]